Zi-Ming Cheng

University of Texas at San Antonio - Division of Hematology and Medical Oncology

San Antonio, TX

United States

SCHOLARLY PAPERS

1

DOWNLOADS

43

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

A Novel RET-GRB2 Fusion in Pheochromocytoma Defies the Classic Paradigm of RET Oncogenic Fusions

Number of pages: 30 Posted: 10 Jan 2022
University of Texas at San Antonio - Division of Hematology and Medical Oncology, University of Texas at San Antonio - Division of Hematology and Medical Oncology, University of Texas at San Antonio - Division of Hematology and Medical Oncology, University of Texas at San Antonio - Division of Hematology and Medical Oncology, University of Massachusetts Worcester - Division of Endocrinology, University of Massachusetts Worcester - Division of Endocrinology, University of Texas at San Antonio - Department of Pathology, University of Texas at San Antonio - Department of Population Health Sciences, University of Texas at San Antonio - Division of Hematology and Medical Oncology and University of Texas at San Antonio - Division of Hematology and Medical Oncology
Downloads 43 (792,353)

Abstract:

Loading...

RET mutation, RET fusion, oncogenic fusion, pheochromocytoma, paraganglioma, tyrosine kinase inhibitor, GRB2, driver genetic events, selpercatinib, pralsetinib